No Data
Dario Introduces Integration of Twill Behavioral Health Capabilities Into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals With Diabetes or Prediabetes
Self-Monitoring Blood Glucose Device Market Report and Company Analysis 2024-2032 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, Novo Nordisk - ResearchAndMarkets.com
Express News | DarioHealth Corp : TD Cowen Cuts Target Price to $3 From $5
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $3
TD Cowen analyst Charles Rhyee maintains $DarioHealth(DRIO.US)$ with a buy rating, and adjusts the target price from $5 to $3.According to TipRanks data, the analyst has a success rate of 48.2% and
DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability